Trial Search Results

Advanced Gastrointestinal Endoscopic Imaging

To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Device: Dual axis endoscopic microscope
  • Device: wide field fluorescence system
  • Device: CellVizio
  • Drug: fluorescent Peptide
  • Drug: fluorescein
  • Drug: indocyanine green




Inclusion Criteria:patients be at least 18 years of age,

Either genders

All ethnic backgrounds will be considered.

Patients who are scheduled for endoscopy by one of the investigators will be asked if they
are interested in participating in the study.

The study will be open to all patients undergoing endoscopy that do not have exclusion
criteria. We will ask all patients if they are participating in any other studies. If they
are participating in any other study then we will ask them for more information to
determine whether there could be any harm from participating in both studies and if there
is then they will not be enrolled. Exclusion Criteria:Patients with unstable vital signs
will not be included.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Cancer Clinical Trials Office, MD